IMPROVEMENT OF SEXUAL AROUSAL, SEXUAL DESIRE, ORGASM AND/OR PLEASURE FOLLOWING INTRAVAGINAL PRASTERONE (DHEA) ADMINISTRATION IN WOMEN NOT SUFFERING OR INDEPENDENTLY FROM DYSPAREUNIA OR OTHER SYMPTOMS OF VULVO-VAGINAL ATROPHY

摘要

The present invention relates to a woman who does not suffer from (1) vulvo-vaginal atrophy symptoms and/or (2) moderate to severe dyspareunia. DHEA (intravaginal) for treating at least one condition selected from the group consisting of (HSDD), female sexual arousal disorder (FSAD), female orgasmic disorder (FOD), and female sexual interest/excitement disorder (SIAD) ( Dihydroepiandrosterone).